Nanotechnology Now

Our NanoNews Digest Sponsors





Heifer International

Wikipedia Affiliate Button


android tablet pc

Home > Press > Elsevier Business Intelligence's 'IN3 Medical Device 360° London' Conference to Feature Exceptional Line-Up of International Device Investors, April 25-26, 2012

Abstract:
Elsevier Business Intelligence, the medtech industry's leading provider of strategic partnership and investment conferences, announces an outstanding roster of presenting senior global investors for its 'IN3 Medical Device 360° London' medical technology investment and partnering conference, being held April 25-26, 2012, at the Millennium Gloucester Hotel & Conference Centre, London Kensington.

Elsevier Business Intelligence's 'IN3 Medical Device 360° London' Conference to Feature Exceptional Line-Up of International Device Investors, April 25-26, 2012

Bridgewater, NJ | Posted on April 6th, 2012

'IN3 Medical Device 360° London' will feature presentations by approximately two dozen early-, mid- and late-stage start-up companies from around the world seeking funding and/or strategic partnership, developing innovative new technologies in the areas of cardiovascular biomaterials, cartilage repair, cancer staging, nanotechnology, neurostimulation, infection control, diagnostics, laparoscopic surgery and much more. Presenting companies to date include: AiMedics, Anethon, CellCoTec, Endomagnetics, Enox BioPharma, Implandata Ophthalmic Products, N8 Medical, NUUBO, QSTREAM VASCULAR, Replication Medical, Sapiens Steering Brain Stimulation, SeamVad, Sensible Medical Innovations, Soft Tissue Regeneration, Specialty Scanners, Vantix, and Vascular Flow Technologies.

The conference also will feature an outstanding agenda of panels and networking sessions with industry thought leaders discussing pressing issues facing the global device industry in 2012 and beyond. Participating speakers include: Edward Andrle, VP, Business Development & Strategy, Sorin Group; Arnaud Bernaert, SVP, Corporate Mergers and Acquisitions, Philips Healthcare; Aris Constantinides, Investment Director, NBGI Ventures; Bulend Corbacioglu, VP, Business Development and Licensing, Covidien; Townsend Goddard, Director, Business Development & Strategic Planning, Stryker; Victor Higgs, Managing Director, Applied Nanodetectors; Alan O'Connell, Partner, Seroba Kernel Life Sciences; Antoine Papiernik, Managing Partner, Sofinnova Partners; Stan Rabinovich, VP, Advanced Technology, Edwards LifeSciences; Thom Rasche, Partner, Earlybird Venture Capital; and Bleddyn Rees, Head of Healthcare, Wragge & Co. LLP, and Director, ECHAlliance.

Panel topics will include: Corporate Buy-Side Perspective: What Are Buyers Looking for in 2012?; Business Challenges Facing Wireless Health Ventures; and Raising Venture Capital in Europe: The Best of Times or the Worst of Times? In addition, the two-day program will feature profile presentations by the following healthcare investment firms, among others: Forbion, Gilde Healthcare Partners, Fountain Healthcare Partners, Wellington Partners, Delta Partners, Peppermint VIP, and Family Office Fund. Partnering software will be available to all registered attendees prior to the conference so that one-on-one onsite meetings can be pre-arranged.

This two-day special event will benefit a wide variety of participants in the global medical device sector: start-ups seeking investment or strategic partnerships, investment firms, VCs, mid-size and large medical device manufacturers, and service providers. Emerging medtech companies that would like to apply to present in London should contact Kayleen Kell at 949-797-7142, or email .

IN3 Medical Device 360° London will be held at the Millennium Gloucester Hotel & Conference Centre, London Kensington. Event co-sponsors to date include Ronald Trahan Associates Inc., Aptiv Solutions, Marketwire, Mass Medical Angels, Life Science Intelligence and Scisive Consulting LP. Visit www.IN3London.com for full conference and registration details. EBI will be hosting two additional IN3 Medical Device 360° events in 2012, in Boston and San Francisco; visit www.elsevierbi.com/conferences for more information.

####

About Elsevier Business Intelligence
Elsevier Business Intelligence (EBI), an Elsevier company built on the heritage of F-D-C Reports, Windhover Information and Medtech Insight, is a global information supplier providing business intelligence on regulatory, business and reimbursement issues that are vital to the healthcare industry. Through a range of products including publications, conferences, databases and reports, EBI places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge, by providing the perfect combination of news and information together with penetrating insight and analysis. EBI (www.elsevierbi.com) has offices in the U.S. in Bridgewater, N.J.; Norwalk, Conn.; Rockville, Md.; and Irvine, Calif.

For more information, please click here

Contacts:
Kayleen Kell
949-797-7142


Ronald Trahan, APR
Ronald Trahan Associates Inc.
508-359-4005, x108

Copyright © Marketwire

If you have a comment, please Contact us.

Issuers of news releases, not 7th Wave, Inc. or Nanotechnology Now, are solely responsible for the accuracy of the content.

Bookmark:
Delicious Digg Newsvine Google Yahoo Reddit Magnoliacom Furl Facebook

Related News Press

News and information

QuantumWise guides the semiconductor industry towards the atomic scale October 24th, 2014

Nanoparticle technology triples the production of biogas October 23rd, 2014

SUNY Polytechnic Institute Invites the Public to Attend its Popular Statewide 'NANOvember' Series of Outreach and Educational Events October 23rd, 2014

Strengthening thin-film bonds with ultrafast data collection October 23rd, 2014

VC/Funding/Angel financing/Loans/Leases/Crowdfunding

TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014

7th Nanotechnology Festival, Exhibition Kicks Off Work in Iran October 7th, 2014

Harris & Harris Group Letter to Shareholders on Website August 19th, 2014

Harris & Harris Group to Host Conference Call on Second-Quarter 2014 Financial Results on August 15, 2014 August 12th, 2014

Investments/IPO's/Splits

TARA Biosystems and Harris & Harris Group Form Company to Improve Safety and Efficacy of New Therapies October 22nd, 2014

Arrowhead Issues Open Letter to Shareholders October 9th, 2014

PEN Inc. Announces New Trading Symbol: PENC: Stock Continues Trading on the OTCQB September 3rd, 2014

Aspen Aerogels, Inc. to Present at Barclays CEO Energy-Power Conference August 27th, 2014

Announcements

QuantumWise guides the semiconductor industry towards the atomic scale October 24th, 2014

SUNY Polytechnic Institute Invites the Public to Attend its Popular Statewide 'NANOvember' Series of Outreach and Educational Events October 23rd, 2014

Advancing thin film research with nanostructured AZO: Innovnano’s unique and cost-effective AZO sputtering targets for the production of transparent conducting oxides October 23rd, 2014

Strengthening thin-film bonds with ultrafast data collection October 23rd, 2014

Events/Classes

Iran-Made Respiratory Nano Masks Provided to Hajj Pilgrims October 23rd, 2014

MEMS & Sensors Technology Showcase: Finalists Announced for MEMS Executive Congress US 2014 October 23rd, 2014

SUNY Polytechnic Institute Invites the Public to Attend its Popular Statewide 'NANOvember' Series of Outreach and Educational Events October 23rd, 2014

NanoTechnology for Defense (NT4D) October 22nd, 2014

NanoNews-Digest
The latest news from around the world, FREE





  Premium Products
NanoNews-Custom
Only the news you want to read!
 Learn More
NanoTech-Transfer
University Technology Transfer & Patents
 Learn More
NanoStrategies
Full-service, expert consulting
 Learn More














ASP
Nanotechnology Now Featured Books




NNN

The Hunger Project







© Copyright 1999-2014 7th Wave, Inc. All Rights Reserved PRIVACY POLICY :: CONTACT US :: STATS :: SITE MAP :: ADVERTISE